Agoracom Blog Home

Archive for the ‘Namaste Technologies Inc.’ Category

Namaste $N.ca $NXTTF signs exclusive distribution agreement with #Shatterizer and announces pod-based #vaporizer collaboration for the Canadian recreational cannabis $ACB.ca $HIP.ca $WEED.ca $CMED.ca

Posted by AGORACOM-JC at 8:59 AM on Monday, May 28th, 2018

  • Signed an exclusive international distribution agreement with Shatterizer Inc.
  • Namaste will retain exclusive rights to sell Shatterizer’s innovative line of cannabis concentrate vaporizers in international markets
  • Company, through its wholly-owned subsidiary Infinite Labz Inc. (“Infinite Labz”), will produce cannabis oil and provide filling and distribution for Shatterizer’s upcoming pod-based concentrate vaporizer system

VANCOUVER, May 28, 2018 – Namaste Technologies Inc. (“Namaste” or the “Company”) (TSXV: N)(FRANKFURT: M5BQ)(OTCMKTS: NXTTF) is pleased to announce that the Company has signed an exclusive international distribution agreement (the “Agreement”) with Shatterizer Inc. (“Shatterizer” or “Shatterizer.com”), whereby Namaste will retain exclusive rights to sell Shatterizer’s innovative line of cannabis concentrate vaporizers in international markets. Namaste is also pleased to announce that the Company will be working with Shatterizer to launch a pod-based vaporizer system for the Canadian recreational market. The Company, through its wholly-owned subsidiary Infinite Labz Inc. (“Infinite Labz”), will produce cannabis oil and provide filling and distribution for Shatterizer’s upcoming pod-based concentrate vaporizer system. Namaste is focused on leveraging its expertise in vaporizer technology within Canada, in an attempt to capitalize on what it anticipates being a significant market for concentrate pens and pre-filled cartridges in both the recreational and medical cannabis markets.

The Shatterizer vaporizer is designed for use with cannabis concentrates and extracts. The demand for high-potency cannabis concentrates has grown exponentially in the US and both Namaste and Shatterizer recognize the opportunity in the Canadian recreational and medical markets. The Shatterizer is engineered to produce a remarkably smooth draw, releasing the fullest flavor through the globe-shaped aluminum atomizer and mouthpiece so that users can enjoy the full-flavored taste of their concentrates. Since its trial launch on Namaste’s Canadian sites, the Shatterizer has received a 4.9/5 star consumer review score and has proven itself to be very popular with Namaste’s customers.

Terms of the Agreement:

  • Namaste will retain exclusive rights to sell Shatterizer products in international markets.
  • Namaste will offer Shatterizer products across its entire platform and stock inventory in its international warehouses.
  • Namaste will adhere to all minimum advertised prices (MAP) set forth by Shatterizer.
  • Shatterizer will provide Namaste’s customer service and sales team with training information and support.
  • Shatterizer will provide warranty support for Namaste’s customers in domestic and international markets.

Namaste anticipates an accelerated demand for cannabis oils and pre-filled cartridges and intends to use its hardware expertise to produce specifically formulated cannabis oil for pod-based vaporizer systems through Infinite Labz. Pre-filled cartridges and pods provide a very simple, discrete and effective means for consuming cannabis oils and extracts. Being the largest international online retailer of vaporizers, Namaste has the unique opportunity to capture early market share of this very significant component of the cannabis industry in the Canadian market. The Company will focus on production of high-quality cannabis oils with healthy margin to be sold through both recreational and medical sales channels. Namaste’s expertise with cannabis hardware and devices will provide a competitive edge in securing its position in this segment of the market.

Management Commentary

Matthew Zysman, President and CEO of Shatterizer comments; “We are thrilled to announce this international distribution deal with Namaste. We are pleased to see how successful we’ve been on their platform and are excited to see this relationship grow.

We at Shatterizer are firm believers that the future of the cannabis industry is in extracts and have built our business around this belief. Shatterizer has quickly become a popular brand amongst cannabis extract enthusiasts, and we are working hard daily to continually surpass our customer’s expectations. This is why we are also thrilled to announce that will be working with Namaste on our new pod-based cannabis vaporizer system in the Canadian market. We are excited to expand our relationship with Namaste, who has shown such great leadership in the cannabis industry and feel that they are the right partners to help us take the Shatterizer brand to the next level.”

Sean Dollinger, President and CEO of Namaste comments; “We are very pleased to have entered into this distribution agreement with Shatterizer. We have been big supporters of the Shatterizer brand and are excited to collaborate on these initiatives. We believe that the company’s management team have a keen sense for market demand and we are aligned in terms of our outlook for the cannabis concentrate market. Our goal with Infinite Labz is to not only produce cannabis extracts but to also provide filling and distribution for pod-based vaporizer systems in which we anticipate seeing an increasing demand for the recreational cannabis market. We look forward to working with Shatterizer as they anticipate launching a new pod-based vaporizer platform in the near future. Namaste will continue to focus on securing similar strategic partnerships with innovative companies to service both recreational and medical cannabis markets.”

About Shatterizer

Shatterizer is focused on satisfying the cannabis concentrates and extracts specific community and growing with it. Customer dedication and continual innovation is the top priority. The company has developed an interchangeable portable vaporizer model, a borosilicate glass Shatterizer version and an aluminum version, increasing the overall product lifestylish-ness. The Shatterizer has come about as a result of personal experiences and the belief in a revolution in what we consume and how we consume it.

About Namaste Technologies Inc.

Namaste Technologies is a global leader in the sale of medical cannabis consumption devices. Namaste has nine offices with multiple distribution centers around the globe and operates over 30 websites under various brands. Namaste has developed innovative technology platforms including NamasteMD.com, Canada’s first ACMPR compliant telemedicine application. The company is focused on patient acquisition through NamasteMD and intends on building Canada’s largest database of medical cannabis patients. The company’s subsidiary, CannMart Inc. is an ACMPR Licensed Producer with a “sales-only” license, whereby the company will offer a large variety of medical cannabis sourced from domestic and international producers. Namaste will continue to develop and acquire innovative technologies which will provide value to the Company and to its shareholders as well as to the broader cannabis market.

On behalf of the Board of Directors

“Sean Dollinger”

Chief Executive Officer

Direct: +1 (786) 389 9771

Email: [email protected]

Further information on the Company and its products can be accessed through the links below:

NamasteTechnologies.com

NamasteMD.com

NamasteVapes.ca

Everyonedoesit.ca

FORWARD-LOOKING INFORMATION This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, Namaste assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The TSXV has neither reviewed nor approved the contents of this press release.

Namaste $N.ca Announces Definitive Agreement to Commercialize Needle-Free Injector Technology for Medical #Cannabis With Inolife R&D Inc. and Participates as Lead Order in Financing Round $ACB.ca $HIP.ca $WEED.ca $CMED.ca

Posted by AGORACOM-JC at 9:06 AM on Wednesday, May 23rd, 2018
  • Company has signed a definitive agreement with Inolife R&D Inc.
  • whereby Namaste is granted exclusive rights to the commercialization of Inolife’s innovative needle-free technology for applications of medical cannabis
  • Namaste intends to produce medical cannabis oil through its partnership with Infinite Labz Inc.

VANCOUVER, May 23, 2018  – Namaste Technologies Inc. (“Namaste” or the “Company”) (TSXV: N)(FRA: M5BQ)(OTCMKTS: NXTTF) is pleased to announce that further to the Letter of Intent (“LOI”) dated March 28th, 2018, the Company has signed a definitive agreement (the “Agreement”) with Inolife R&D Inc. (“Inolife”), whereby Namaste is granted exclusive rights to the commercialization of Inolife’s innovative needle-free technology for applications of medical cannabis, in accordance with Health Canada regulations.

Namaste intends to produce medical cannabis oil through its partnership with Infinite Labz Inc. (“Infinite Labz”) and to specifically formulate oil for use with Inolife’s injector technology. The Company believes that needle-free injection of cannabis oils could prove to be one of the most effective means of dosing through a painless device, with a fast absorption rate. Namaste will work with Inolife’s management team to develop standardized production procedures for oil production, and for testing or studies required to commercialize the technology for applications of medical cannabis in accordance with federal regulations.

Namaste is also pleased to announce that the Company is participating as the lead order in a non-brokered private placement offering (“Private Placement”), whereby Namaste will purchase 2,000,000 units of Inolife, issued at a price of $0.10 per unit. Each unit consists of one common share and one-half of one common share purchase warrant, with an exercise price of $0.20 per full warrant for a period of 24 months from the Private Placement closing date. Inolife has also chosen to appoint Namaste’s CEO Sean Dollinger to Inolife’s executive board of directors. Namaste’s management team believes that Inolife’s needle-free technology can offer significant long-term value for the medical cannabis market.

Key Terms of the Agreement

  • Namaste shall have and retain exclusive rights to the procurement and/or production of the oil required to meet the requirements and standards set out and outlined in the testing, studies, and evaluations of the products in accordance with Health Canada and/or any other regulatory agency requirements.
  • During the term of the Agreement, further testing, studies, and evaluations may be required by a regulatory agency or third party that may be interested in utilizing the needle-free injectors for the commercial use in the medical cannabis industry.
  • During the term of the Agreement, Namaste and Inolife must agree on who will conduct the testing, studies, and evaluations of the needle-free injectors.
  • The purpose of testing, studies, and evaluations of the needle-free injectors shall be primarily to determine the method on how to best produce medical cannabis oil that would be suitable for needle-free injection.
  • The Agreement shall extend to any future technology and implementations of the Inolife products, such as needle-free injectors using Inolife’s powder-based system.

Management Commentary

Michael Wright, President and CEO of Inolife comments, “The relationship between Inolife and Namaste heralds a new era for the medical cannabis industry. We’re pleased to see the opportunities for our innovative needle-free device technology to be used to deliver cutting-edge treatment from medical cannabis. Our commitment to improving quality of life for patients remains at the forefront of all our endeavors and we feel that Namaste will be an excellent partner.”

Sean Dollinger, President, and CEO of Namaste comments; “We are very excited to have signed the definitive agreement with Inolife. We are focused on partnerships with companies with innovative technology, and Inoflie’s technology could revolutionize the way medical patients with severe conditions are able to meter accurate doses of cannabis in a safe, effective and pain-free way. We anticipate that upon commercialization, Namaste will be able to leverage its relationships to produce pre-filled injectors with medical cannabis. I’m very pleased to be joining Inolife’s board of directors and hope to offer value to their team. We feel strongly that our investment and partnership with Inolife will create strong, long-term value for both companies and their shareholders.”

About Inolife R&D Inc.

Inolife R&D Inc. is an emerging, specialty medical device company focused on developing and commercializing self-administered medical products using novel drug delivery technologies. The company was founded to take advantage of novel techniques of liquid jet and ballistics-based epidermal drug injection. We believe this technology will improve a patient’s quality of life by making medicines more effective and easier to self-administer, and that it will also eliminate the anxiety and inconvenience associated with hypodermic needle injections.

About Namaste Technologies Inc.

Namaste Technologies is a global leader in the sale of medical cannabis consumption devices. Namaste has nine offices with multiple distribution centers around the globe and operates over 30 websites under various brands. Namaste has developed innovative technology platforms including NamasteMD.com, Canada’s first ACMPR compliant telemedicine application. The company is focused on patient acquisition through NamasteMD and intends on building Canada’s largest database of medical cannabis patients. The company’s subsidiary, CannMart Inc. is an ACMPR Licensed Producer with a “sales-only” license, whereby the company will offer a large variety of medical cannabis sourced from domestic and international producers. Namaste will continue to develop and acquire innovative technologies which will provide value to the Company and to its shareholders as well as to the broader cannabis market.

On behalf of the Board of Directors

“Sean Dollinger”

Chief Executive Officer

Direct: +1 (786) 389 9771

Email: [email protected]

Further information on the Company and its products can be accessed through the links below:

NamasteTechnologies.com
NamasteMD.com
NamasteVapes.ca
Everyonedoesit.ca

FORWARD-LOOKING INFORMATION This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, Namaste assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Neither the TSX Venture Exchange nor its market regulator has reviewed or approved the contents of this press release.

SOURCE Namaste Technologies Inc.

View original content with multimedia: http://www.newswire.ca/en/releases/archive/May2018/23/c2011.html

Sean Dollinger, Chief Executive Officer, Direct: +1 (786) 389 9771, Email: [email protected]; Vancouver, BC, V6C 2B5, Main : + 1 (786) 389-9771, namastetechnologies.com, [email protected] CNW Group 2018

 

VANCOUVER, May 23, 2018  – Namaste Technologies Inc. (“Namaste” or the “Company”) (TSXV: N)(FRA: M5BQ)(OTCMKTS: NXTTF) is pleased to announce that further to the Letter of Intent (“LOI”) dated March 28th, 2018, the Company has signed a definitive agreement (the “Agreement”) with Inolife R&D Inc. (“Inolife”), whereby Namaste is granted exclusive rights to the commercialization of Inolife’s innovative needle-free technology for applications of medical cannabis, in accordance with Health Canada regulations.

Namaste intends to produce medical cannabis oil through its partnership with Infinite Labz Inc. (“Infinite Labz”) and to specifically formulate oil for use with Inolife’s injector technology. The Company believes that needle-free injection of cannabis oils could prove to be one of the most effective means of dosing through a painless device, with a fast absorption rate. Namaste will work with Inolife’s management team to develop standardized production procedures for oil production, and for testing or studies required to commercialize the technology for applications of medical cannabis in accordance with federal regulations.

Namaste is also pleased to announce that the Company is participating as the lead order in a non-brokered private placement offering (“Private Placement”), whereby Namaste will purchase 2,000,000 units of Inolife, issued at a price of $0.10 per unit. Each unit consists of one common share and one-half of one common share purchase warrant, with an exercise price of $0.20 per full warrant for a period of 24 months from the Private Placement closing date. Inolife has also chosen to appoint Namaste’s CEO Sean Dollinger to Inolife’s executive board of directors. Namaste’s management team believes that Inolife’s needle-free technology can offer significant long-term value for the medical cannabis market.

Key Terms of the Agreement

  • Namaste shall have and retain exclusive rights to the procurement and/or production of the oil required to meet the requirements and standards set out and outlined in the testing, studies, and evaluations of the products in accordance with Health Canada and/or any other regulatory agency requirements.
  • During the term of the Agreement, further testing, studies, and evaluations may be required by a regulatory agency or third party that may be interested in utilizing the needle-free injectors for the commercial use in the medical cannabis industry.
  • During the term of the Agreement, Namaste and Inolife must agree on who will conduct the testing, studies, and evaluations of the needle-free injectors.
  • The purpose of testing, studies, and evaluations of the needle-free injectors shall be primarily to determine the method on how to best produce medical cannabis oil that would be suitable for needle-free injection.
  • The Agreement shall extend to any future technology and implementations of the Inolife products, such as needle-free injectors using Inolife’s powder-based system.

Management Commentary

Michael Wright, President and CEO of Inolife comments, “The relationship between Inolife and Namaste heralds a new era for the medical cannabis industry. We’re pleased to see the opportunities for our innovative needle-free device technology to be used to deliver cutting-edge treatment from medical cannabis. Our commitment to improving quality of life for patients remains at the forefront of all our endeavors and we feel that Namaste will be an excellent partner.”

Sean Dollinger, President, and CEO of Namaste comments; “We are very excited to have signed the definitive agreement with Inolife. We are focused on partnerships with companies with innovative technology, and Inoflie’s technology could revolutionize the way medical patients with severe conditions are able to meter accurate doses of cannabis in a safe, effective and pain-free way. We anticipate that upon commercialization, Namaste will be able to leverage its relationships to produce pre-filled injectors with medical cannabis. I’m very pleased to be joining Inolife’s board of directors and hope to offer value to their team. We feel strongly that our investment and partnership with Inolife will create strong, long-term value for both companies and their shareholders.”

About Inolife R&D Inc.

Inolife R&D Inc. is an emerging, specialty medical device company focused on developing and commercializing self-administered medical products using novel drug delivery technologies. The company was founded to take advantage of novel techniques of liquid jet and ballistics-based epidermal drug injection. We believe this technology will improve a patient’s quality of life by making medicines more effective and easier to self-administer, and that it will also eliminate the anxiety and inconvenience associated with hypodermic needle injections.

About Namaste Technologies Inc.

Namaste Technologies is a global leader in the sale of medical cannabis consumption devices. Namaste has nine offices with multiple distribution centers around the globe and operates over 30 websites under various brands. Namaste has developed innovative technology platforms including NamasteMD.com, Canada’s first ACMPR compliant telemedicine application. The company is focused on patient acquisition through NamasteMD and intends on building Canada’s largest database of medical cannabis patients. The company’s subsidiary, CannMart Inc. is an ACMPR Licensed Producer with a “sales-only” license, whereby the company will offer a large variety of medical cannabis sourced from domestic and international producers. Namaste will continue to develop and acquire innovative technologies which will provide value to the Company and to its shareholders as well as to the broader cannabis market.

On behalf of the Board of Directors

“Sean Dollinger”

Chief Executive Officer

Direct: +1 (786) 389 9771

Email: [email protected]

Further information on the Company and its products can be accessed through the links below:

NamasteTechnologies.com
NamasteMD.com
NamasteVapes.ca
Everyonedoesit.ca

FORWARD-LOOKING INFORMATION This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, Namaste assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Neither the TSX Venture Exchange nor its market regulator has reviewed or approved the contents of this press release.

SOURCE Namaste Technologies Inc.

View original content with multimedia: http://www.newswire.ca/en/releases/archive/May2018/23/c2011.html

Sean Dollinger, Chief Executive Officer, Direct: +1 (786) 389 9771, Email: [email protected]; Vancouver, BC, V6C 2B5, Main : + 1 (786) 389-9771, namastetechnologies.com, [email protected] CNW Group 2018

Namaste $N.ca Closes Acquisition of Leading #A.I. and Machine-Learning Technology Platform Findify.io for $12,000,000 in Cash and Shares $ACB.ca $HIP.ca $WEED.ca $CMED.ca

Posted by AGORACOM-JC at 9:21 AM on Tuesday, May 22nd, 2018

Namaste large new

  • Announced that the Company has closed its previously announced acquisition of Swedish-based A.I. and machine learning technology platform, Findify AB
  • Findify is a global leader in A.I. powered e-commerce technology, delivering solutions such as personalized search, recommendations, and advanced data analytics

VANCOUVER, May 22, 2018 – Namaste Technologies Inc. (“Namaste” or the “Company“) (TSXV: N) (FRA: M5BQ) (OTCMKTS: NXTTF) is pleased to announce that the Company has closed its previously announced acquisition of Swedish-based A.I. and machine learning technology platform, Findify AB (“Findify” or “Findify.io”), through the purchase of all of the issued and outstanding shares of Findify, for a purchase price of US $12,000,000 in a combination of cash and common shares of the Company. Findify is a global leader in A.I. powered e-commerce technology, delivering solutions such as personalized search, recommendations, and advanced data analytics. The acquisition of Findify as a technology platform will bring significant value to Namaste and its shareholders by accelerating the Company’s growth strategy, enhancing conversion rates and revenue and in providing an entry into machine-learning and A.I. for applications for cannabis.

Findify’s Platform and Conversion Rate Optimization

Findify’s platform, which is used by leading e-commerce websites, including Namaste, uses proprietary real-time machine learning algorithms to deliver a truly personalized experience to each and every customer. Through robust data collection, the platform analyzes user behavior and in combination with product trends, it automatically and continuously displays relevant products to each customer at any given time. The ability to deliver accurate and relevant products real-time, leads to increases in revenue, conversion rates and average order value.

Namaste will deploy Findify’s full product suite across its platform in order to bring this intelligence across all consumer touch-points. This focus on conversion rate optimization (CRO) using A.I. and machine learning technology will provide Namaste’s customers and patients, with an enhanced user experience while also increasing sales. The Company’s management team anticipates that the integration of Findify’s full-suite of proprietary technology will increase monetization, deliver a better user experience for customers, and propel revenue growth in both cannabis and hardware sales.

Cannabis A.I.

The Namaste and Findify team are pleased to be bringing the power of artificial intelligence to solve the problem of unpredictability in plant medicine. Findify’s technology will help bring clarity to our consumers and patients, who seek a specific cannabis strain in an ocean of variety, misinformation, uncertainty. Recent studies have revealed that the cannabis plant has 144 cannabinoids and over 100 terpenes, each with beneficial properties in unique combinations, affecting individuals in different ways. In addition to having over a thousand strains and over 200 variations of beneficial compounds, humans have different responses to each of these strains, making it an enormous challenge to find the right strain for the right person and their particular needs. Today, we search for that perfect strain by means of trial & error or guesswork. But Findify’s proprietary machine learning technology will allow us to match each unique individual with the relevant cannabis products for them. The Findify acquisition uniquely positions Namaste to develop a cannabis-focused A.I. platform that will provide a deeper understanding of patients needs and behaviours in an effort to provide a more relevant and personalized experience.

Key terms of the Acquisition:

  • Namaste acquired all issued and outstanding shares of Findify in exchange for:
    • US $2,000,000 in cash, paid upon the closing date of the proposed transaction.
    • US $10,000,000 paid in common shares of Namaste at a mutually agreed price of C$1.80 per common share.

The acquisition of Findify represents a major milestone for Namaste as its largest and first technology-based acquisition. Namaste will roll-out the entire suite of products available through Findify on all touch points in order to bring real-time intelligence across its platform. Findify will also leverage their experience working with 1000+ e-commerce stores, with conversion rate optimization and enhanced UX design.

Management Commentary

Meni Morim, Founder and CEO of Findify comments:

“We are delighted to officially be part of the Namaste Technologies team. We believe that technology can make the world a better place, and we strive to achieve that vision by bringing plant-based holistic medicine to the masses. By leveraging the power of A.I., we can understand complex plant characteristics and match them with patients’ profiles, thus helping patients with ailments such as chronic pain find the right strain of cannabis to alleviate their condition. It’s exciting to be able to use Namaste’s platform to offer people in remote areas access to health professionals and high-quality products.

During the acquisition process, we had the opportunity to work closely with the Namaste management team. It is an incredibly experienced and talented group of people, with drive and dedication which is truly inspiring. We are honored to be part of such a team.

We have spent a significant time reviewing the vision and roadmap of Namaste, and we’re very excited to take part in shaping the future of cannabis. We will be working hard on weaving A.I. into all aspects of the Namaste offering, which will deliver an unparalleled experience to our customers and patients.”

Sean Dollinger, President and CEO of Namaste comments:

“We are very excited to have acquired such an innovative company. Findify’s team have demonstrated themselves to be not only cutting-edge developers but also like-minded in business and strategy. We have already seen the benefits of A.I. and machine-learning in applications of e-commerce and anticipate strong growth in Findify’s existing business, offering this as a service to retailers. Our strategy will be to roll-out the full-suite of Findify’s offering across all Namaste sites with a focus on increasing CRO and in maximizing revenue and profitability. We have devoted ourselves to acquiring and innovating technology for the cannabis industry. We are very excited to have the opportunity to begin testing machine-learning and A.I. applications specifically within the cannabis industry.

In the future, cannabis patients will demand a more personalized online experience, as products and services in the cannabis industry continue to grow exponentially. We remain focused on positioning the company as a global leader in applications of innovative technology within the cannabis industry. We are very proud to have such talented companies and individuals working in partnership with Namaste to enhance a patient’s online buying experience by providing a deeper level personalization that will directly impact the patient’s experience.”

About Findify AB

Findify is a leader in e-commerce machine learning applications, with over 1200 customers in more than 60 countries around the world. Findify has developed a unique machine learning core, that leverages user behaviour, to personalize online experiences in real-time. Findify’s machine learning technology has been proven to deliver up to 27% uplift in conversion rate, and up to 30% uplift in revenue per user.

Findify is an official Shopify Plus Technology Partner, recognized as a “Best-In-Class Solution” for modern, rapidly growing e-Commerce businesses.

About Namaste Technologies Inc.

Namaste Technologies is a global leader in the sale of medical cannabis consumption devices. Namaste has nine offices with multiple distribution centers around the globe and operates over 30 websites under various brands. Namaste has developed innovative technology platforms including NamasteMD.com, Canada’s first ACMPR compliant telemedicine application. The company is focused on patient acquisition through NamasteMD and intends on building Canada’s largest database of medical cannabis patients. The company’s subsidiary, CannMart Inc. is an ACMPR Licensed Producer with a “sales-only” license, whereby the company will offer a large variety of medical cannabis sourced from domestic and international producers. Namaste will continue to develop and acquire innovative technologies which will provide value to the Company and to its shareholders as well as to the broader cannabis market.

On behalf of the Board of Directors

“Sean Dollinger”

Chief Executive Officer

Investor Relations

Phone: 561-542-5052 or 250-300-5103

Email: [email protected]

Further information on Namaste and its products can be accessed through the links below:

namastetechnologies.com

namastevapes.ca

everyonedoesit.ca

namastevaporizers.co.uk

everyonedoesit.co.uk

australianvaporizers.com.au

Forward-Looking Information

This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, Namaste assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents, which can be found under the Company’s profile on www.sedar.com. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward looking statements are made pursuant to the safe harbour provisions of the Private Securities Litigation Reform Act of 1995. Neither the TSX Venture Exchange nor its market regulator has reviewed or approved the contents of this press release.

SOURCE Namaste Technologies Inc.

Namaste $N.ca Announces Updates to NamasteMD Patient Acquisition Portal and Appointment of Baran Dilaver as Interim COO $ACB.ca $HIP.ca $WEED.ca $CMED.ca

Posted by AGORACOM-JC at 9:00 AM on Monday, May 14th, 2018

Namaste large new

  • Announced the integration of several critical updates to the Company’s online patient acquisition tool, NamasteMD Inc.
  • Company’s revolutionary mobile app, which is available on desktop, Apple IOS and Android devices, has allowed Namaste to accelerate patient growth at a rate that exceeds any industry peers and at significantly lower cost per patient

VANCOUVER, British Columbia, May 14, 2018 – Namaste Technologies Inc. (“Namaste” or the “Company”) (TSXV:N) (FRANKFURT:M5BQ) (OTCMKTS:NXTTF) is pleased to announce the integration of several critical updates to the Company’s online patient acquisition tool, NamasteMD Inc. (“NamasteMD”). NamasteMD, which is the Company’s revolutionary mobile app, which is available on desktop, Apple IOS and Android devices, has allowed Namaste to accelerate patient growth at a rate that exceeds any industry peers and at significantly lower cost per patient. NamasteMD is presently ranked as the #2 Medical application in the Canadian Apple Store. NamasteMD provides a simple digital platform for patients to acquire medical cannabis documentation from the comfort of their home. Since its initial launch, the Company has acquired over 2,000 patients exclusively through organic growth without any paid advertising. The Company believes that the recent updates to the app will allow Namaste to fully deploy its marketing strategy and accelerate growth in what the Company believes will soon be Canada’s largest database of medical cannabis patients.

With this release patients now have a more streamlined and reliable video experience, enabled by our trusted partner Twilio. This release also includes stability and performance improvements, including a fix for a bug that was preventing a small percentage of our users from logging in. The Company will focus on continued updates to increase the acceleration rate of its patient database through organic and paid advertising channels.

Additionally, the Company would like to announce that co-founder Kory Zelickson is transferring roles to become Vice President of Business Development and Investor Relations, and that Baran Dilaver will be appointed as the Company’s interim Chief Operating Officer. With the Company’s rapid expansion, Kory will focus on the growth of the Company in the areas of business development, strategic partnership and in investor relations and hand-off operations to Baran Dilaver, who has many years of experience in operations. This strategic decision will allow both Kory and Baran to excel in each of their respective areas to further propel the growth of the Company. Mr. Baran Dilaver has extensive experience in running companies and for the past three months, Baran Dilaver has been focused on improving Namaste’s operations and organizing its various business divisions. The Company welcomes Baran in joining as Interim COO and believes that these changes will provide further value to its shareholders. Upon his appointment, Baran Dilaver commented: “I am thrilled to have such a critical role in shaping Namaste’s future, and I am in a great position to lead the recruitment of a world class COO to hand over some of the initiatives I started here with the operations and finance teams.”

About Baran Dilaver

Baran is an entrepreneur, creator, and an accomplished executive.  He launched several well-known brands worldwide and conceived and developed over 80 products.  Baran is the founder of FutureScape, a technology focused product design and branding company and recently, as the COO and CMO at Firefly Vapor, he created and implemented business strategies that established Firefly as one of the most admired brands in the cannabis industry.  Prior to Firefly, Baran Dilaver was the CEO of United Brands, a leading food technology company based out of San Francisco. He is a speaker in conferences like Tech Open Air Berlin, CannaTech, and European Communications Summit.  He was a scholar athlete at UC Berkeley and studied Economics.  He loves kitesurfing and snowboarding around the world and building large-scale art installations at Burning Man.

Management Commentary

Sean Dollinger, President and CEO of Namaste comments; “We’re very pleased to have had major updates approved to the NamasteMD platform. I believe that NamasteMD provides the Company with a competitive edge in being the first company in Canada to fully digitize patient acquisition. At a cost of only $60 per patient, Namaste is able to acquire patients at a much lower cost than our peers who require the use of physical clinics or doctors to acquire patients. In a very short period of time we have managed to acquire over 2,000 patients organically with zero spend on marketing or promotion. At this point of the business cycle we now feel that the platform is ready for full launch and anticipate an even more significant acceleration of growth over the next several months through a strategic marketing campaign.

Additionally, I’m very pleased to have Kory focus on his areas of expertise in business development and investor communications where he brings major value to the Company. We have been continuously growing as a company and Kory has filled in as COO, but we have now decided to have each team member focus exclusively in their areas of expertise. The investor relations and business development role is very important to the Company and Kory is best fit for this role. We are also very pleased to be bringing on Baran Dilaver as interim COO who has many years of experience in the industry and as someone who has developed a deep level of understanding of Namaste’s global operations. Moving forward we are in a prime position to leverage an amazing management team and innovative technology to advance as a global leader in all things cannabis.”

About Namaste Technologies Inc.

Namaste Technologies is a global leader in the sale of medical cannabis consumption devices. Namaste has nine offices with multiple distribution centers around the globe and operates over 30 websites under various brands. Namaste has developed innovative technology platforms including NamasteMD.com, Canada’s first ACMPR compliant telemedicine application. The company is focused on patient acquisition through NamasteMD and intends on building Canada’s largest database of medical cannabis patients. The company’s subsidiary, CannMart Inc. is an ACMPR Licensed Producer with a “sales-only” license, whereby the company will offer a large variety of medical cannabis sourced from domestic and international producers. Namaste will continue to develop and acquire innovative technologies which will provide value to the Company and to its shareholders as well as to the broader cannabis market.

On behalf of the Board of Directors

“Sean Dollinger”

Chief Executive Officer

Direct: +1 (786) 389 9771

Email: [email protected]

Further information on the Company and its products can be accessed through the links below:

NamasteTechnologies.com

NamasteMD.com

NamasteVapes.ca

Everyonedoesit.ca

FORWARD LOOKING INFORMATION This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, Namaste assumes no responsibility to update or revise forward looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The TSXV has neither reviewed nor approved the contents of this press release.

Namaste $N.ca Opens the Market $ACB.ca $HIP.ca $WEED.ca $CMED.ca

Posted by AGORACOM-JC at 11:41 AM on Thursday, May 10th, 2018

Nlogo

TORONTO, May 10, 2018 – Sean Dollinger, President and CEO, Namaste Technologies Inc. (N), joined Brady Fletcher, Managing Director, TSX Venture Exchange, to open the market. Namaste Technologies is a global online retailer for medical cannabis delivery systems. Namaste distributes vaporizers and smoking accessories through over 30 e-commerce sites in 20 countries. Namaste Technologies Inc. commenced trading on TSX Venture Exchange on May 2, 2018.

SOURCE TMX Group Limited

View original content with multimedia: http://www.newswire.ca/en/releases/archive/May2018/10/c8978.html

Namaste $N.ca Announces Signing of a Definitive Agreement to Acquire 51% of the Outstanding Shares of Infinite Labz $ACB.ca $HIP.ca $WEED.ca $CMED.ca

Posted by AGORACOM-JC at 10:54 AM on Thursday, May 10th, 2018

Nlogo

  • Further to the April 5th announcement of an LOI with 2624078 Ontario Inc., the Company has signed a Share Purchase Agreement to acquire 51% of the outstanding shares of 2624078 Ontario Inc. (“Infinite Labz”)
  • Agreed to finance the construction of Infinite Labz’s facility in Etobicoke, Ontario

VANCOUVER, British Columbia, May 10, 2018 – Namaste Technologies Inc. (“Namaste” or the “Company”) (TSXV:N) (FRANKFURT:M5BQ) (OTCMKTS:NXTTF) is pleased to announce that further to the April 5th announcement of an LOI with 2624078 Ontario Inc., the Company has signed a Share Purchase Agreement (“SPA”) to acquire 51% of the outstanding shares of 2624078 Ontario Inc. (“Infinite Labz”) and has agreed to finance the construction of Infinite Labz’s facility in Etobicoke, Ontario.

Infinite Labz intends to submit an application to become a Health Canada Licensed Producer (“LP”) of medical cannabis oil, with the intention of resale to both the medical and recreational markets. Infinite Labz also intends to apply to become a Licensed Dealer (“LD”) of medical cannabis in accordance with Health Canada regulations, allowing the company to initiate research and development, import cannabis, perform analytical testing, and conduct clinical studies with medical cannabis, dried flower, and oil.

Namaste anticipates an accelerated demand for cannabis oils and believes that a dedicated facility designed for the sole purpose of producing oils and extracts can provide the Company with a strong supply of high-margin oil products. Following completion of construction and licensing, the facility will allow Infinite Labz to produce oils and extracts at a low cost for sale to registered patients of Namaste’s wholly owned subsidiary, Cannmart Inc. (“Cannmart”), resulting in increased  margins for Namaste.  Inifinite Labz also plans to produce and sell oils/extracts directly to other LP’s, and participate in the recreational market by selling its products to licensed provincial distributors. The Company also intends to use its hardware experience to produce specialized pod-based vaporization systems for use with oil formulations.  Namaste has established a strong brand through its existing retail channels and intends on building on that unique brand in the Cannabis oil sector through Infinite Labz.

If an LD license is obtained, Infinite Labz will facilitate importation of medical cannabis for testing purposes, following which an application for approval from Health Canada to import for resale purposes can be made. The LP license, in combination with the LD license would allow Infinite Labz to gain full exposure to the exciting segment of the medical cannabis industry through importation, testing, and production of cannabis oils and extracts.

Key SPA terms:

  • Namaste will provide financing, through a first priority shareholder loan, of up to $750,000 for construction of the Infinite Labz facility.
  • Namaste’s shareholder loan will be re-paid from net profits.
  • Namaste will acquire 51% of the outstanding shares of Infinite Labz.
  • Infinite Labz management team has entered into consulting agreements to oversee construction of the facility and the applications for the LP and LD licences.

Management Commentary

Sean Dollinger, President and CEO of Namaste comments: “We are very pleased to have entered into a definitive agreement as we believe that the facility at Infinite Labz can be instrumental in allowing Namaste to participate in the recreational market. In addition, the facility would allow Namaste to control the production and distribution of cannabis oil for sale through Cannmart, as well as for resale to LP’s. We believe that having the ability to offer oil production services for smaller craft producers through Infinite Labz will add significant value moving forward as we look to develop relationships with all types of LPs that enable us to provide our patients with a broad range of cannabis products. Our hope is that these services will lead to additional opportunities with LP’s who see value in working collaboratively. In addition to producing oil through the facility, Cannmart plans on providing oil filling services for pre-filled cartridges and vaporizers pods once approved by Health Canada. This facility will not only support the Company’s growth in the sale of medical cannabis but it will also ensure that we stay ahead of the curve in anticipation of federal changes to the legal cannabis industry.”

About Namaste Technologies Inc.

Namaste Technologies is a global leader in the sale of medical cannabis consumption devices. Namaste has nine offices with multiple distribution centers around the globe and operates over 30 websites under various brands. Namaste has developed innovative technology platforms including NamasteMD.com, Canada’s first ACMPR compliant telemedicine application. The company is focused on patient acquisition through NamasteMD and intends on building Canada’s largest database of medical cannabis patients. The company’s subsidiary, CannMart Inc. is an ACMPR Licensed Producer with a “sales-only” license, whereby the company will offer a large variety of medical cannabis sourced from domestic and international producers. Namaste will continue to develop and acquire innovative technologies which will provide value to the Company and to its shareholders as well as to the broader cannabis market.

On behalf of the Board of Directors

“Sean Dollinger”

Chief Executive Officer

Direct: +1 (786) 389 9771

Email: [email protected]

Further information on the Company and its products can be accessed through the links below:

NamasteTechnologies.com

NamasteMD.com

NamasteVapes.ca

Everyonedoesit.ca

FORWARD LOOKING INFORMATION

This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, Namaste assumes no responsibility to update or revise forward looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The CSE has neither reviewed nor approved the contents of this press

Namaste $N.ca $NXTTF Signs Exclusive Drop-Shipping Agreement With Ample Organics Enabling Ample’s Licensed Producer Customers to Sell Vaporizers and Accessories $ACB.ca $HIP.ca $WEED.ca $CMED.ca

Posted by AGORACOM-JC at 9:49 AM on Monday, May 7th, 2018

  • Signed an exclusive drop-shipping supply agreement with Ample Organics Inc.
  • Ample Organics is Canada’s leading seed-to-sale software platform, currently used by the majority of Canada’s licensed producers of medical cannabis
  • Namaste will connect its cannabis hardware and accessory platform via API integration with Ample Organics’ system

VANCOUVER, British Columbia, May 07, 2018 — Namaste Technologies Inc. (“Namaste” or the “Company”) (TSXV:N) (FRA:M5BQ) (OTCMKTS:NXTTF) is pleased to announce that the Company has signed an exclusive drop-shipping supply agreement (the “Agreement”) with Ample Organics Inc. (“Ample Organics”). Ample Organics is Canada’s leading seed-to-sale software platform, currently used by the majority of Canada’s licensed producers of medical cannabis (“LPs”). Under the terms of the Agreement, Namaste will connect its cannabis hardware and accessory platform via API integration with Ample Organics’ system. This will allow each of Ample Organics’ LP customers to have instant access to a large variety of devices and accessories available for purchase during checkout. The Agreement will provide added value for Ample Organics customers by offering their patients industry-leading products. Namaste is proud to have this unique opportunity in partnering with Canada’s most innovative seed-to-sale software company and this Agreement clearly demonstrates Namaste’s continued focus on achieving technological development for the cannabis industry.

Key Terms of the Agreement

  • Namaste will supply Ample Organics customers with access to the Company’s full range of vaporizers and accessories through an API integration, as the exclusive drop-shipping supplier to Ample Organics.
  • Namaste will have first right of refusal to supply new products as requested by Ample Organics, or its customers, for drop-shipping through the API integration.
  • In the event that Namaste decides not to carry a new product or cannot source such product within 30 days, Ample Organics will be granted the right to offer the new product using drop-shipping through a 3rd party supplier.
  • Each order will be submitted electronically via API integration that will also provide live access to tracking information, inventory and shipping data.
  • Namaste will be responsible, at its cost for all product support, returns and warranty claims.
  • Unless Namaste advises otherwise, solely due to pricing restrictions from the product manufacturers, Ample Organics and its customers shall agree to set the prices for the Products at a Minimum Advertised Price (MAP), to be specified by Namaste for each product.

Namaste’s partnership with Ample Organics represents a unique opportunity to provide virtually hundreds of thousands of medical cannabis patients with access to a variety of high-quality vaporizers, which research has shown is a far superior and healthier way to consume medical cannabis. This agreement further demonstrates Namaste’s commitment to the medical cannabis patients of Canada, and in ensuring that they have easy and affordable access to the best cannabis hardware products on the market.

The Agreement represents an important step for Namaste and is accretive in nature, as it will provide immediate, low-overhead revenue for both Namaste and Ample Organics. The Company will now focus its efforts on completing the integration with Ample Organics as soon as possible and will continue to explore further opportunities that have the potential to bring value to Namaste, its partners, and the entire cannabis market.

Management Commentary

John X. Prentice, President and CEO of Ample Organics comments; “This partnership represents a substantial value-add for Ample Organics’ clients and their patient customers. It will simplify inventory management and fulfillment for LPs, while ensuring that medical cannabis patients across the country have access to a substantial catalogue of vaporizers and cannabis accessories at great prices. We are excited to continue the development of our relationship with Namaste and look forward to advancing the industry in new and innovative ways together.”

Sean Dollinger, President and CEO of Namaste comments; “We are very proud to be partnered with Ample Organics on this project. It’s been very rewarding to collaborate with the management team, on what we believe is an important initiative for all those involved, most importantly of which are the medical cannabis patients of Canada. We are incredibly excited to be associated with Ample Organics and to have the opportunity to provide healthier, more affordable options for medical patients to consume cannabis. Our commitment to developing a platform with easily accessible products and services for the cannabis industry is what inspired the opportunity to work with Ample Organics. We’re looking forward to completing the integration and to further enhancing the patient experience.”

About Ample

Ample Organics is Canada’s leading cannabis business solution, adopted by 75% of the nation’s Licensed Producers. To date, the Ample Organics platform has processed more than 880,000 orders and 16,000,000 grams of cannabis. Ample Organics makes compliance easy by tracking individual plants from seed to consumer and reporting every detail of the growth, production, and sales processes. With Ample Organics, data is collected at the most granular levels, offering insights that can drive business decisions and help to protect public safety. Beyond seed to sale, Ample Organics’ extended suite of products creates a complete ecosystem for cannabis businesses. From easy patient registration to cannabis-exclusive payment solutions, Ample Organics continues to evolve and release new products to provide reliable and compliant solutions for the cannabis industry.

About Namaste Technologies Inc.

Namaste Technologies is a global leader in the sale of medical cannabis consumption devices. Namaste has nine offices with multiple distribution centers around the globe and operates over 30 websites under various brands. Namaste has developed innovative technology platforms including NamasteMD.com, Canada’s first ACMPR compliant telemedicine application. The company is focused on patient acquisition through NamasteMD and intends on building Canada’s largest database of medical cannabis patients. The company’s subsidiary, CannMart Inc. is an ACMPR Licensed Producer with a “sales-only” license, whereby the company will offer a large variety of medical cannabis sourced from domestic and international producers. Namaste will continue to develop and acquire innovative technologies which will provide value to the Company and to its shareholders as well as to the broader cannabis market.

On behalf of the Board of Directors,

Sean Dollinger
Chief Executive Officer
Direct: +1 (786) 389 9771
Email: [email protected]

Further information on Namaste and its products can be accessed through the links below:

namastetechnologies.com
namastevapes.ca
everyonedoesit.ca
namastevaporizers.co.uk
everyonedoesit.co.uk
australianvaporizers.com.au

For more information about Ample Organics, please visit ampleorganics.com or contact:
Peter Slater
VP, Corporate Development
Direct: +1 (416) 262-4175
Email: [email protected]

Forward Looking Information

This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, Namaste assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents, which can be found under the Company’s profile on www.sedar.com. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward looking statements are made pursuant to the safe harbour provisions of the Private Securities Litigation Reform Act of 1995. The Canadian Securities Exchange has neither reviewed nor approved the contents of this press release.

Namaste $N.ca Acquires #Findify, a Leading A.I. and Machine Learning Company, to Increase Conversion Rates, Average Order Value, Retention and Referrals $ACB.ca $HIP.ca $WEED.ca $CMED.ca

Posted by AGORACOM-JC at 11:06 AM on Wednesday, May 2nd, 2018

Nlogo

  • Company executed a definitive agreement to acquire all of the issued and outstanding shares of Findify AB
  • purchase price of US $12,000,000 in a combination of cash and common shares of the Company
  • Findify is a global leader in A.I. powered e-commerce personalization, delivering solutions such as personalized search, recommendations, and advanced data analytics

VANCOUVER, British Columbia, May 02, 2018 – Namaste Technologies Inc. (“Namaste” or the “Company”) (TSX-V:N) (FRA:M5BQ) (OTCMKTS:NXTTF) is pleased to announce that on May 1, 2018 the Company executed a definitive agreement to acquire (the “Acquisition”) all of the issued and outstanding shares of Findify AB (a Swedish corporation, “Findify”), for a purchase price of US $12,000,000 in a combination of cash and common shares of the Company. Findify is a global leader in A.I. powered e-commerce personalization, delivering solutions such as personalized search, recommendations, and advanced data analytics. Among its customers are Nine West, PLV Shoes, and Rocketdog.

Management expects the integration of Findify’s proprietary technology to increase monetization and propel revenue growth in both cannabis and hardware sales. In addition to anticipated growth in Namaste’s core business, the Company will allocate resources to expand on Findify’s existing platform and expects this to result in increased EBITDA by the end of 2019. Namaste also anticipates accelerating patient growth through its wholly owned subsidiary and Canada’s first fully-compliant online patient portal, NamasteMD Inc. (“NamasteMD” or “NamasteMD.com”). By implementing Findify’s technology in applications of patient acquisition, conversion rates, order value and customer retention, the Company expects to reach 50,000 medical cannabis patients by the end of 2018 and up to 100,000 by the end of 2019.

Findify’s platform which is used by leading e-commerce websites, including Namaste, uses proprietary real-time machine learning algorithms to build unique user profiles, and deliver a personalized experience for each user. The platform continuously learns from user behavior to automatically improve search results, recommendations, and product landing pages, displaying the most relevant products at any given time. It identifies product trends and, in combination with an analysis of unique customer behavior, ranks products in a way to optimize revenue, conversion rates and average order value. Based on the Bank of Canada’s exchange rate on May 1, 2018, Findify’s annual 2017 revenue was $503,170 and its first quarter 2018 revenue was $198,211.

Key terms of the Acquisition:

  • Namaste will acquire all issued and outstanding shares of Findify in exchange for:
    • US $2,000,000 in cash to be paid upon the closing date of the transaction.
    • US $10,000,000 to be paid in common shares of Namaste at a mutually agreed price of C$1.80 per common share.

Key designated employees of Findify will be remaining with the company after the completion of the acquisition.

The acquisition of Findify brings an incredible amount of value to the Company in applications related to the online retail of medical cannabis. Namaste recognizes this as a unique opportunity to offer medical cannabis patients an even more personalized experience. The acquisition of Findify will reinforce Namaste’s goal of becoming the global leader in cannabis technology solutions by further expanding its innovative e-commerce platform and enhancing the user experience for cannabis patients globally.

In addition, the acquisition of Findify creates a new revenue stream for the Company in the field of artificial intelligence and data analytics. Namaste will continue to operate and expand on Findify’s existing platform and client portfolio.  Namaste anticipates rapid expansion of its technology licensing business.

Management Commentary

Meni Morim, Founder and CEO of Findify comments: “The Findify team is very excited to join the Namaste family, and take part in revolutionizing the online cannabis domain. The team brings years of experience, having built a unique machine learning platform that leverages user behavior, to deliver a personalized e-commerce experience across touchpoints, with a focus on search & discovery. We believe that Namaste’s strong positioning in the market will enable us to take advantage of this technology in the best possible way, and deliver immediate value to customers and shareholders – by buildings the world’s first fully integrated A.I. platform for cannabis.

Having built a relationship with Namaste as a client over the past two years, we found that we share many of the same core values, work ethic, and passion for building products that people love. We’re confident that the merging of our teams will enable us to continue innovating in this fast-paced, growing industry.”

Laurens Feenstra, Director of Namaste, an A.I. expert, and Product Manager for Google Waymo comments: “I am super excited for the talented team of Findify to join Namaste! Their leading machine learning models have already made Namaste much better at recommending the right products to our customers. And, even more importantly, we are thrilled to apply their deep A.I. expertise to cannabis. There are approximately 800 identified strains of cannabis each with hundreds of active ingredients, meaning each plant works differently for each person. Understanding which plant works for whom will be key in helping cannabis benefit everyone.”

Sean Dollinger, President and CEO of Namaste comments: “We’re very pleased to announce the acquisition of Findify. This is a very exciting opportunity for Namaste to forge new ground in the cannabis industry by introducing what we believe to be the most innovative technology for on-site personalization. Moving forward we believe global cannabis patients will demand a more customized online experience, as products and services in the cannabis industry continue to grow exponentially. Having worked with Findify as a client, we have witnessed excellent results through the implementation of their technology and believe strongly in the quality of their management team. Based on the success we have seen in the utilization of similar technology in other industries, we are extremely excited and optimistic to become the first company to introduce this incredible technology into the cannabis market and further enhance the online experience for cannabis patients.

Our vision for the Company in becoming a global leader in medical cannabis technology is evident from the addition of our new board members coming from Google and SpaceX, industry leaders in the areas of machine learning and A.I. that chose to join Namaste’s team. Furthermore, this acquisition represents a major milestone for Namaste in solidifying itself as one of the most innovative technology companies in the cannabis industry.”

About Findify AB

Findify is a leader in e-commerce machine learning applications, with over 1200 customers in more than 60 countries around the world. Findify has developed a unique machine learning core, that leverages user behaviour, to personalize online experiences in real-time. Findify’s machine learning technology has been proven to deliver up to 27% uplift in conversion rate, and up to 30% uplift in revenue per user.

Findify is an official Shopify Plus Technology Partner, recognized as a “Best-In-Class Solution” for modern, rapidly growing e-Commerce businesses.

About Namaste Technologies Inc.

Namaste Technologies is a global leader in the sale of medical cannabis consumption devices. Namaste has nine offices with multiple distribution centers around the globe and operates over 30 websites under various brands. Namaste has developed innovative technology platforms including NamasteMD.com, Canada’s first ACMPR compliant telemedicine application. The company is focused on patient acquisition through NamasteMD and intends on building Canada’s largest database of medical cannabis patients. The company’s subsidiary, CannMart Inc. is an ACMPR Licensed Producer with a “sales-only” license, whereby the company will offer a large variety of medical cannabis sourced from domestic and international producers. Namaste will continue to develop and acquire innovative technologies which will provide value to the Company and to its shareholders as well as to the broader cannabis market.

On behalf of the Board of Directors

“Sean Dollinger”
Chief Executive Officer
Direct: +1 (786) 389 9771
Email: [email protected]

Further information on Namaste and its products can be accessed through the links below:
namastetechnologies.com
namastevapes.ca
everyonedoesit.ca
namastevaporizers.co.uk
everyonedoesit.co.uk
australianvaporizers.com.au

Forward Looking Information

This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, Namaste assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents, which can be found under the Company’s profile on www.sedar.com. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward looking statements are made pursuant to the safe harbour provisions of the Private Securities Litigation Reform Act of 1995. Neither the TSX Venture Exchange nor its market regulator has reviewed or approved the contents of this press release.

Namaste $N.ca Receives Final Approval to List on TSX Venture Exchange $ACB.ca $HIP.ca $WEED.ca $CMED.ca

Posted by AGORACOM-JC at 9:36 AM on Tuesday, May 1st, 2018

Nlogo

  • Received final approval to list the common shares and warrants of the Company on the TSX Venture Exchange as a Tier 1 issuer
  • Common shares and warrants of the Company will be delisted from the Canadian Securities Exchange at the close of trading on May 1, 2018 and listed on the TSXV at the opening of trading on May 2, 2018

VANCOUVER, British Columbia, May 01, 2018 – Namaste Technologies Inc. (“Namaste” or the “Company”) (CSE:N) (FRA:M5BQ) (OTCMKTS:NXTTF) is pleased to announce that the Company has received final approval to list the common shares and warrants of the Company on the TSX Venture Exchange (“TSXV”) as a Tier 1 issuer. The common shares and warrants of the Company will be delisted from the Canadian Securities Exchange at the close of trading on May 1, 2018 and listed on the TSXV at the opening of trading on May 2, 2018. The Company’s common shares will continue to trade under the symbol “N” and its warrants will continue to trade under the symbol “N.WT.” The Company believes that listing on the TSXV will provide Namaste and its shareholders with many advantages, including greater visibility and enhanced market access for Canadian and international investors.

Management Commentary

Sean Dollinger, President and CEO of Namaste comments: “We are very pleased to have received final approval to list on the TSXV as a Tier 1 issuer. We’re proud to have reached a point where the Company will gain more exposure through a larger market and to join many of our peers on the TSXV. We’d like to thank our shareholders and management team for their continued support. This is certainly an exciting day in the history of Namaste and we look forward to a bright future.”

About Namaste Technologies Inc.

Namaste is the largest online retailer for medical cannabis delivery systems globally. Namaste distributes vaporizers and smoking accessories through e-commerce sites in 24 countries and with 5 distribution hubs located around the world. Namaste has majority market share in Europe and Australia, with operations in the UK, Canada and Germany and has opened new supply channels into emerging markets including Brazil, Mexico and Chile. Namaste, through its acquisition of Cannmart Inc., which operates a medical cannabis “sales-only” license under Canada’s Access to Cannabis for Medical Purposes Regulations (“ACMPR”), is pursuing a new revenue vertical in online retail of medical cannabis in the Canadian market. Namaste intends to leverage its existing database of Canadian medical cannabis consumers, along with its expertise in ecommerce to create an online marketplace for medical cannabis patients, offering a larger variety of product and a better user experience.

On behalf of the Board of Directors

“Sean Dollinger”

Chief Executive Officer

Direct: +1 (786) 389 9771

Email: [email protected]

 

Further information on Namaste and its products can be accessed through the links below:

namastetechnologies.com

namastevapes.ca

everyonedoesit.ca

namastevaporizers.co.uk

everyonedoesit.co.uk

australianvaporizers.com.au

Forward Looking Information

This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, Namaste assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents, which can be found under the Company’s profile on www.sedar.com. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward looking statements are made pursuant to the safe harbour provisions of the Private Securities Litigation Reform Act of 1995. The Canadian Securities Exchange has neither reviewed nor approved the contents of this press release.

Namaste $N.ca $NXTTF Announces Record-Breaking Quarterly Sales of $5.6M Representing a 195% Quarter-Over-Quarter Increase and Over 1,600 Medical Cannabis Patients $ACB.ca $HIP.ca $WEED.ca $CMED.ca

Posted by AGORACOM-JC at 10:09 AM on Monday, April 30th, 2018

Nlogo

  • Sales for the second quarter of 2018 were $5.6M,
    • representing a $3.7M or 195% increase quarter-over-quarter 
  • Gross profit for the second quarter of 2018 was $1.9M,
    • representing a $1.2M or 150% increase quarter-on-quarter
  • Over 1,600 Medical Cannabis Patients Acquired To-Date Through NamasteMD

VANCOUVER, British Columbia, April 30, 2018 — Namaste Technologies Inc. (“Namaste” or the “Company”) (CSE:N), (FRANKFURT:M5BQ), (OTCMKTS:NXTTF) is pleased to announce the filing of its unaudited quarterly financial statements, management’s discussion and analysis and certification of the quarterly filings for the second quarter of fiscal 2018. The statements for the period can be accessed on the Company’s SEDAR profile at www.sedar.com.

The Company’s sales for the second quarter of 2018 were $5.6M, representing a $3.7M or 195% increase quarter-over-quarter.  Gross profit for the second quarter of 2018 was $1.9M, representing a $1.2M or 150% increase quarter-on-quarter. For the first six months of the year, the Company had sales of $10.6M, representing a $6.6M or 165% increase year-on-year. Gross profit for the first six months of 2018 was $3.6M, representing a $2.1M or 140% increase year-over-year. The gross profit increase relates primarily to the growth in revenue outside the United States.

Namaste’s management team is extremely encouraged by the financial position of the Company and anticipates seeing accelerated growth in Q3 and Q4 of 2018. The Company has been focused on launching many new initiatives, the most significant of which is the addition of medical cannabis sales through the Company’s wholly-owned subsidiary, Cannmart Inc. (“Cannmart”). Namaste will focus on expanding its international platform and in developing new opportunities domestically and abroad.

The Company has also seen a significant impact on Canadian operating costs for its hardware business, correlated to the integration of Namaste’s platform with Greenlane Canada Inc., whereby inventory management and order processing are fulfilled by Greenlane. The integration with Greenlane has completely removed all inventory costs and has also streamlined operations. The Company anticipates further cost reductions by pursuing similar strategic partnerships which bring long-term value to the Company and its shareholders.

Namaste’s management team is now highly focused on patient acquisition through the Company’s innovative telemedicine application, NamasteMD. To date, the company has acquired over 1,600 patients, all of which were driven organically through Namaste’s platform. The Company’s marketing team will be working through various marketing channels to further accelerate patient growth while expanding its clinic team in order to accommodate anticipated demand. With strong initial results on patient acquisition costs and conversion rates, Namaste believes that it will be able to acquire medical patients faster and at a lower cost than any of its industry peers.

The Company is also looking forward to trading on the TSX Venture Exchange (“TSXV”) as a Tier 1 issuer, which will provide Namaste and its shareholders with many advantages, including greater visibility and enhanced market access for Canadian and international investors.

Quarterly Financial Highlights

  • The majority of revenues were generated by several key markets. The top five countries generated 85% of revenues for the second quarter of 2018 compared to 84% for the second quarter of 2017. The table below depicts gross revenues by country.
Revenues by country
For three months ended For six months ended
Country February 28,
2018
February 28,
2017
February 28,
2018
February 28,
2017
United Kingdom $1,346,193.00 $737,946.00 $2,580,175.81 $1,285,227.00
Australia $1,234,429.00 $91,371.00 $2,650,200.00 $170,254.62
United States of America $1,140,217.00 $525,518.00 $1,817,768.84 $1,437,529.00
Brazil $380,879.00 $100,591.00 $735,322.92 $202,514.00
Canada $678,815.00 $78,985.00 $1,034,446.63 $159,223.00
Germany $287,878.00 $32,660.00 $550,487.86 $56,097.00
New Zealand $71,714.00 $75,149.00 $176,197.59 $209,317.00
Ireland $36,902.00 $51,759.00 $98,722.14 $87,264.00
Israel $94,160.00 $26,367.00 $157,004.13 $48,603.00
Other $362,643.00 $186,760.00 $764,614.08 $338,265.38
Total $5,633,830.00 $1,907,106.00 $10,564,940.00 $3,994,294.00
  • Operating costs for the second quarter of 2018 were $5.5M compared to $2.4M for the second quarter of 2017. The $3.1M quarter-over-quarter increase in operating costs is primarily due to non-cash charges of $1.5M, which included share-based compensation, amortization of intangible assets, and depreciation.
  • Selling expenses for the second quarter of 2018 were $1.7M compared to $0.6M for the second quarter of 2017, representing an increase of $1.1M quarter-on-quarter. The increase was due in part to an increase in advertising expenses of $0.6M and consulting expenses of $0.5M. Advertising expenses related to online search services as well as other online promotional and social media tools utilized by the Company to generate sales. These costs further represent the Company’s significant investment into search engine optimization and its ongoing customer acquisition strategy. Consulting expenses relate to compensation amounts paid to various companies and individuals for marketing, order fulfillment, customer service activities, e-commerce product development, back-office e-commerce support and sales commissions. The increase in consulting fees is primarily related to information technology in order to develop current and new revenue channels.
  • Administration expenses for the second quarter of 2018 were $3.5M compared to $1.8M for the second quarter of 2017, representing an increase of $1.7M quarter-over-quarter. The increase is primarily due to share-based compensation of $1.3M and increases in merchant fees and professional fees.
  • Other expenses for the second quarter of 2018 were $0.3M compared to approximately $nil for the second quarter of 2017, representing an increase of $0.3M quarter-over-quarter. The increase was primarily due to the amortization of intangibles of $0.2M, which relates to the amortization of the customer list from the acquisition of Australian Vaporizers.

Management Commentary
Sean Dollinger, President and CEO of Namaste comments: “We are very pleased with the Q2 financials. The Company continues to see quarter-on-quarter growth at a rapidly accelerating rate, even after having divested our US assets. Our management team remains focused on ramping up patient acquisition through NamasteMD, and we anticipate launching medical cannabis sales through Cannmart in the near future. Namaste will continue to pursue and develop innovative technologies for the cannabis industry. This will be achieved through forming mutually beneficial partnerships and in making strategic investments that bring value to both the Company and the cannabis sector as a whole. We feel that the Company is now positioned for significant growth going forward which will be achieved by accelerating patient acquisition, adding medical cannabis sales to our platform and by implementing new technologies to an already impressive platform.”

About Namaste Technologies Inc.
Namaste is the largest online retailer for medical cannabis delivery systems globally. Namaste distributes vaporizers and smoking accessories through e-commerce sites in 24 countries and with 5 distribution hubs located around the world. Namaste has majority market share in Europe and Australia, with operations in the UK, Canada and Germany and has opened new supply channels into emerging markets including Brazil, Mexico and Chile. Namaste, through its acquisition of Cannmart Inc., which operates a medical cannabis “sales-only” license under Canada’s Access to Cannabis for Medical Purposes Regulations (“ACMPR”), is pursuing a new revenue vertical in online retail of medical cannabis in the Canadian market. Namaste intends to leverage its existing database of Canadian medical cannabis consumers, along with its expertise in e-commerce to create an online marketplace for medical cannabis patients, offering a larger variety of product and a better user experience.

Forward Looking Information
This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com.

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The CSE has neither reviewed nor approved the contents of this press release.

On behalf of the Board of Directors
“Sean Dollinger”
Chief Executive Officer Direct: +1 (786) 389 9771
Email: [email protected]

Further information on Namaste and its products can be accessed through the links below:

www.namastetechnologies.com
www.namastevaporizers.co.uk
www.everyonedoesit.co.uk
www.australianvaporizers.com.au